Drug Industry Fights Against Biden's Prescription Drug Reforms

Pharmaceutical companies and House Republicans are attacking President Joe Biden's new Medicare drug reforms, which have already started to lower prescription costs for seniors. The pharmaceutical industry is challenging one key component of the new prescription drugs initiative in court, while a caucus representing most House Republicans is calling to repeal the entire program through legislation. The legal challenge officially got a new and powerful champion on Wednesday when the industry trade group PhRMA filed a lawsuit claiming that the new law’s best-known feature violates the Constitution in multiple ways.